Today: 4 April 2026
Subscribe

Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

Intellia Therapeutics (NTLA) Soars on CRISPR Breakthroughs – Latest Updates & Stock Outlook

Why Intellia Therapeutics’ Stock Could Be a Gene‑Editing Goldmine in 2025 – Deep Dive into NTLA’s Prospects

Intellia shares surged to $26.14 on Oct. 8, up 72.6% over the past month, after Phase 1 data showed its CRISPR therapy reduced serum TTR by 92% at 24 months. The company reported Q2 revenue of $14.2 million and a narrowed net loss per share of $0.98. Cash reserves stood at $630 million. Analyst consensus rates the stock a “Moderate Buy” with targets averaging $27–34.
8 October 2025
··
CRISPR Therapeutics Stock Update (Oct 8 2025): Why Gene‑Editing Bulls See Big Upside

CRISPR Therapeutics Stock Update (Oct 8 2025): Why Gene‑Editing Bulls See Big Upside

CRISPR Therapeutics (NASDAQ: CRSP) closed at $77.73 on Oct. 8, 2025, up 10% for the day and nearly 20% for the month. Trading volume reached 3.1 million shares, with the price moving between $70.77 and $78.38. The company’s market cap stood at $6.2 billion, and analysts’ average one-year price target was $81. CRSP remains pre-profit, reporting a Q2 net loss of $208.5 million on $0.9 million in revenue.
8 October 2025
·
Intellia Therapeutics (NTLA) Soars on CRISPR Breakthroughs – Latest Updates & Stock Outlook

Intellia Therapeutics (NTLA) Soars on CRISPR Breakthroughs – Latest Updates & Stock Outlook

Intellia’s NTLA-2001 gene editing therapy cut TTR protein by about 90% for three years in transthyretin amyloidosis patients, with improved outcomes and no new safety issues, according to data presented Sept. 25 and published in NEJM. Enrollment finished for the Phase 3 HAELO trial of NTLA-2002, with top-line results expected in 1H 2026. Intellia stock is up over 60% in 2025. Q2 revenue more than doubled to $14.25 million.
8 October 2025
···
TSMC Stock Soars on AI Boom: Record Highs, Big Ambitions & Geopolitical Risks (Oct 2025 Update)

TSMC Stock Soars on AI Boom: Record Highs, Big Ambitions & Geopolitical Risks (Oct 2025 Update)

TSMC shares hover near record highs, up about 45% in 2024, as Q2 revenue surged 44% year-on-year to $30.1 billion on AI chip demand. Morgan Stanley and Bank of America raised targets ahead of Q3 results due Oct. 16. Taiwan rejected U.S. calls to split chip output, while Chinese drills raised energy security concerns. TSMC aims to start 2nm chip mass production by late 2025.
8 October 2025
··
Cisco’s $2B AI Windfall: New Tech, Stock Surge & What’s Next for CSCO

Cisco’s $2B AI Windfall: New Tech, Stock Surge & What’s Next for CSCO

Cisco unveiled a 51.2 Tbps router and Silicon One P200 chip for AI data centers on Oct. 8, 2025, with Microsoft and Alibaba as initial buyers. Fiscal 2025 revenue reached $56.7 billion, up 5%, and AI-focused orders topped $2 billion. Shares trade near $69 with a 2.4% dividend yield. Wall Street rates the stock a “Moderate Buy,” with an average 12-month price target of $74–75.
8 October 2025
··
UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

UnitedHealth Group Stock Surges Amid Analyst Upgrades: Is Wall Street Turning Bullish on UNH in 2025?

UnitedHealth Group closed near $372 on Oct. 8, up over 2%, but remains far below its April high of $630. The company reported $422.8 billion in trailing 12-month revenue and $21.3 billion net income. Analysts raised price targets after recent upgrades, but the stock faces pressure from rising medical costs and regulatory probes. Third-quarter results are due Oct. 28, with guidance cut to $14.65 per share.
8 October 2025
·
Reddit’s Stock Explodes! 78% Revenue Surge, Google AI Deal Talks & 70% Rally 🔥

Reddit’s Rollercoaster: How Booming Ads, AI Deals and Political Scrutiny Could Shock RDDT Investors

Reddit shares traded near $199.54 midday Oct. 8, after reporting its first profitable quarter with $500 million in revenue and 110.4 million daily users. Analyst price targets rose, with RBC citing ad growth and JMP, Oppenheimer, and Piper Sandler setting targets at $290–$300. Reddit named Aleph its exclusive ad partner in 45+ markets. The U.S. House summoned Reddit’s CEO over radicalization concerns after the Charlie Kirk assassination.
8 October 2025
··
Palo Alto Networks’ AI-Fueled Surge: Stock Soars on Cybersecurity Boom, Bold Forecasts & Big Deals

Palo Alto Networks’ AI-Fueled Surge: Stock Soars on Cybersecurity Boom, Bold Forecasts & Big Deals

Palo Alto Networks traded near $216 on October 8, 2025, approaching multi-month highs and a $135–140 billion market cap. Unit 42 uncovered a major China-linked hacking campaign targeting foreign ministries’ emails. Fiscal Q4 revenue rose 16% to $2.5 billion, with adjusted EPS up 16% to 95¢. Wall Street maintains a strong buy rating, with price targets averaging $215–220.
8 October 2025
···
Confluent, Inc. (CFLT) – Will a Real‑Time Data Pioneer Become a Takeover Target? (October 8 2025)

Unraveling Confluent (CFLT) Stock: Latest Price, AI‑Driven Buzz & What Experts Say

Confluent closed at $22.84 on Oct. 8, down 10% after Reuters reported the company is exploring a sale following interest from private-equity and tech firms. The stock surged 20% pre-market on the news and remains volatile. Q2 results showed 21% subscription revenue growth, but management warned of slower cloud consumption. Market cap stands near $7.3 billion, with a 52-week range of $15.64 to $37.90.
8 October 2025
··
AI Drug Discovery Darling? Recursion Pharma (RXRX) Stock’s Wild Ride in 2025

AI Drug Discovery Darling? Recursion Pharma (RXRX) Stock’s Wild Ride in 2025

Recursion Pharmaceuticals’ stock jumped 16% to $6.08 on October 8, 2025, after falling over 5% the previous day. The company uses AI to accelerate drug discovery and recently reported Q2 revenue of $19.2 million, up 33% year-over-year, but posted a net loss of $171.9 million. Recursion holds about $534 million in cash. Recent moves include acquiring Exscientia and cutting several pipeline programs.
8 October 2025
···
AiRWA (YYAI) Stock Soars 44% on $100M Crypto Pivot – Expert Insights

AiRWA (YYAI) Stock Soars 44% on $100M Crypto Pivot – Expert Insights

AiRWA Inc. (Nasdaq: YYAI), formerly Connexa Sports, rebranded and shifted to blockchain, securing a $100 million commitment from JuCoin Capital and receiving $30 million in Solana tokens. Shares jumped 32% to $0.2375 on Oct. 8 after plunging 92.8% the prior day. Market cap stands at $3.8 million with high short interest. The company faces SEC warnings over continued operations despite reporting FY2025 revenue of $12.8 million.
8 October 2025
··
AST SpaceMobile (ASTS) Stock Skyrockets on Verizon Deal – Is Satellite-to-Phone Broadband the Next Big Thing?

AST SpaceMobile (ASTS) Stock Skyrockets on Verizon Deal – Is Satellite-to-Phone Broadband the Next Big Thing?

AST SpaceMobile shares surged over 200% in 2025, hitting all-time highs after announcing a direct-to-phone satellite service deal with Verizon. The agreement, unveiled October 8, aims to launch space-based cellular coverage for Verizon customers in 2026. AST’s satellites have already enabled live voice and video calls to standard phones. The company’s market value reached about $14 billion.
8 October 2025
·
Webull’s Wild Ride: Inside BULL Stock’s 500% Surge, 85% Crash & What’s Next for the Trading App Giant

Webull’s Wild Ride: Inside BULL Stock’s 500% Surge, 85% Crash & What’s Next for the Trading App Giant

Webull (NASDAQ: BULL) surged nearly 500% to $79.56 after its April 2025 SPAC debut, then plunged over 85%; shares traded near $12 on Oct. 8, just above their 52-week low. A lock-up expiration in October released 455.6 million insider shares, triggering a two-day selloff. Q2 revenue rose 46% to $131.5 million, but the company remains unprofitable on a net basis. Analysts set price targets near $18.50, citing strong growth.
8 October 2025
·
Nuburu’s Blue Laser Revolution: Defense Pivot Propels BURU Stock to Skyrocket

Nuburu’s Blue Laser Revolution: Defense Pivot Propels BURU Stock to Skyrocket

Nuburu, Inc. (NYSE American: BURU) shares surged over 300% to $0.68 intraday on Oct. 8, 2025, after defense-related announcements, lifting market cap to $60 million. The company, founded in 2015 in Colorado, reported Q2 revenue of $49,000 and a net loss of $12.2 million. Alessandro Zamboni and Dario Barisoni became co-CEOs on Oct. 1. Nuburu is shifting from industrial lasers to defense technology.
8 October 2025
··
90% Plunge to 1000% Upside? Acurx Pharmaceuticals (ACXP) Stock Sees EMA Boost & Bold Analyst Predictions

90% Plunge to 1000% Upside? Acurx Pharmaceuticals (ACXP) Stock Sees EMA Boost & Bold Analyst Predictions

Acurx Pharmaceuticals shares have fallen about 90% from their 52-week high, trading near $4.30 after a 1-for-20 reverse split in August. The stock briefly rallied in late September after the European Medicines Agency issued a positive opinion on its pediatric plan for ibezapolstat. Acurx remains pre-revenue with $6.1 million in cash at Q2’s end and faces additional funding needs for Phase 3 trials.
8 October 2025
·
Confluent, Inc. (CFLT) – Will a Real‑Time Data Pioneer Become a Takeover Target? (October 8 2025)

Confluent (CFLT) Stock Surges on Takeover Rumors – What’s Next for the Data Streaming Pioneer?

Confluent, Inc. shares surged nearly 20% in pre-market trading October 8 after Reuters reported the company is exploring a sale amid acquisition interest. The stock jumped to around $24.70, near analysts’ average 12-month target, but remains down about 25% year-to-date. Confluent posted Q2 revenue of $282 million, up 20% year-over-year, but is not yet GAAP-profitable. The company trades at a premium, with a ~$7 billion market cap.
8 October 2025
··
QuantumScape (QS) Stock Skyrockets 14% on Solid-State EV Battery Breakthrough – Can the Rally Continue?

QuantumScape’s High-Voltage Surge: Solid-State Battery Breakthrough Sends QS Stock Soaring (Oct 2025 Update)

QuantumScape shares closed at $15.92 on Oct. 3, up 11% for the day and 170% year-to-date, after announcing a partnership with Corning to co-develop battery separators. At the Munich auto show, Volkswagen’s Ducati prototype using QuantumScape cells demonstrated rapid charging and high energy density. Most analysts still rate the stock “Sell” or “Hold,” citing a lack of product revenue.
8 October 2025
······
EU’s 50% Steel Tariff Shocker Spurs “Existential” UK Crisis Amid Market Rally

EU’s 50% Steel Tariff Shocker Spurs “Existential” UK Crisis Amid Market Rally

The European Commission plans to double steel import tariffs to 50% and halve tariff-free quotas, citing a need to block cheap Chinese steel. UK industry leaders warn the move threatens thousands of British steel jobs, with 78–80% of UK steel exports going to the EU. European steel stocks surged up to 5% after the announcement. UK Prime Minister Keir Starmer said urgent talks with Brussels are underway to seek exemptions.
8 October 2025
Tesla’s ‘Affordable’ EV Gamble Backfires – Stock Sinks as Cheaper Models Disappoint Investors

Tesla’s ‘Affordable’ EV Gamble Backfires – Stock Sinks as Cheaper Models Disappoint Investors

Tesla launched lower-cost “Standard” versions of the Model Y and Model 3, priced at $39,990 and $36,990, dropping some premium features but offering over 300 miles of range. Shares fell about 4% after the announcement, as investors and analysts questioned whether the modest price cuts would boost demand. Tesla’s Q3 2025 deliveries hit a record 497,000, but analysts expect a Q4 slowdown after the U.S. tax credit expired.
8 October 2025
··
1 … 250 251 252 253 254 … 361

Stock Market Today

  • Pembroke VCT Boosts Capital with B Share Allotment as Market Liquidity Rises
    April 4, 2026, 7:59 AM EDT. Pembroke VCT plc, a UK-listed venture capital trust, has allotted 5.18 million new B Ordinary Shares, raising fresh capital for its high-growth portfolio. The shares, priced at 100.2p based on unaudited net asset value as of December 2025, will trade on the London Stock Exchange around April 9, 2026. This move increases total B shares to nearly 299 million, enhancing market liquidity. The company's diversified venture investments benefit from this capital injection amid persistent negative free cash flow and volatile results. Analyst consensus holds a 'Hold' rating with a £94 price target. Pembroke VCT operates under the UK's FCA rules, targeting smaller, growth-oriented firms and providing investors tax advantages linked to venture capital trusts (VCTs).
Go toTop